The 1.5% convertible senior notes are due 2029

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by iRhythm Technologies, Inc. of $661.25 million aggregate principal amount of its 1.50% convertible senior notes due 2029, which included the full exercise of the initial purchasers’ option to purchase additional notes. In addition, Davis Polk advised the counterparties to the capped call transactions entered into by iRhythm in connection with the offering.

iRhythm Technologies, Inc. is a leading digital healthcare company that creates trusted solutions that detect, predict and help prevent disease. Its principal business is the design, development and commercialization of device-based technology to provide ambulatory cardiac monitoring services. iRhythm is based in San Francisco, California.

The Davis Polk corporate team included partner Alan F. Denenberg, counsel Jason Bassetti and associates Paula Gergen and Jacquiley Wong. The equity derivatives team included partner Mark M. Mendez, counsel Hanbing Zhang and associate Ji Hwan Kim. The tax team included partner Lucy W. Farr and associate Justin Corvino. The intellectual property team included partner David R. Bauer. Members of the Davis Polk team are based in the Northern California and New York offices.